Gufic Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 41 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 1.36 Cr
About Gufic Pharma
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1983PLC006323
-
Company No.
006323
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 1983
-
Date of AGM
07 Aug 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Gufic Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jerry
|
Director | 07-Mar-2014 | Current |
|
Prince Elias
|
Director | 15-Feb-2016 | Current |
|
Sandeep Mehandroo
|
Director | 30-Nov-2012 | Current |
Financial Performance of Gufic Pharma.
Gufic Pharma Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gufic Pharma?
In 2017, Gufic Pharma had a promoter holding of 98.00% and a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sun Pharmaceutical Medicare LimitedPrince Elias is a mutual person
-
Vivaldis Health And Foods Private LimitedSanjay Jerry is a mutual person
-
Caraco Pharmaceuticals Private LimitedSanjay Jerry and Prince Elias are mutual person
-
Neetnav Real Estate Private Limited
Sanjay Jerry and Prince Elias are mutual person
-
Realstone Multitrade Private Limited
Sanjay Jerry and Prince Elias are mutual person
-
Faststone Mercantile Company Private Limited
Sanjay Jerry and Prince Elias are mutual person
Charges (Loans)
₹0
₹13.63 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.76 Cr
- The Saraswat Co-Operative Bank Ltd : 0.35 Cr
- Bharat Overseas Bank Ltd : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 1992 | The Saraswat Co-Operative Bank Ltd | ₹3.50 M | Satisfied |
| 06 Feb 1990 | Bharat Overseas Bank Ltd | ₹2.50 M | Satisfied |
| 11 Jan 1990 | Canara Bank | ₹0.50 M | Satisfied |
| 19 Oct 1985 | Canara Bank | ₹1.00 M | Satisfied |
| 24 Jul 1984 | Canara Bank | ₹3.60 M | Satisfied |
How Many Employees Work at Gufic Pharma?
Unlock and access historical data on people associated with Gufic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gufic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gufic Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
